(Q39018678)

English

Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants

scientific article published on 18 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Japanese encephalitis virus

0 references

1 reference

based on heuristic

inferred from title

attenuated vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Japanese encephalitis

1 reference

based on heuristic

inferred from title

measles vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

corrigendum / erratum

Corrigendum to “Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants” [Vaccine 26 (2008) 2234–2241]

1 reference

10.1016/J.VACCINE.2013.11.002

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1016/J.VACCINE.2013.11.002

Kathleen Neuzil

7

object named as

Kathleen M Neuzil

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

5

object named as

Sutee Yoksan

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Salvacion Gatchalian

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Yafu Yao

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Benli Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Lei Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Kim Kelly

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Mansour Yaïch

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Julie Jacobson

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

18 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

2234-2241

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.042

7 January 2021

Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.042

7 January 2021

Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.042

7 January 2021

Vaccines administered simultaneously: directions for new combination vaccines based on an historical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.042

7 January 2021

Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.042

7 January 2021

Immunogenicity of Measles and Rubella Vaccines in Oman: A Prospective Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.042

7 January 2021

Effect of vitamin A supplementation on measles vaccination in nine-month-old infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.042

7 January 2021

Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.042

7 January 2021

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.042

7 January 2021

Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.042

7 January 2021

Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.042

7 January 2021

Study of combined vaccination against yellow fever and measles in infants from six to nine months

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.042

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.02.042

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39018678&oldid=1802525642"